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ABSTRACT
Background: Although HPV is the most common sexually transmitted disease in the United States, vaccination rates are still
lagging among adolescents and young adults. Entertainment-education is a popular strategy for incorporating educational
messages into entertainment media. With popular shows on television now integrating health messages into their narrative, there
are more opportunities to influence knowledge, attitude and health behaviors. Objective: To (a) determine the effectiveness of the
HPV narrative included in the “Someone You love” documentary on HPV risk perception, vaccine self-efficacy and behavioral
intention for HPV vaccine uptake on college students and (b) assess the immediate impact of the documentary on HPV vaccine
initiation.
Methods: A dependent samples t-test was conducted to determine if differences in the scale scores for each variable existed
between pre and post viewing. Scale items were measured on a 7-point Likert scale and summed for analyses.
Results: Students (n=126) participated in four screenings. Participants were mostly female (76.5%), freshman (40%), Caucasian
(48.3%), heterosexual (81.5%) and sexually active (74.3%). The results showed a positive and significant effect from pre- and
post-test scores on Risk Perception 7.150, t (119) = 14.502, p.
Discussion: While the documentary shares light on the impact of HPV transmission and its deadly impact, no formal research
study has been done to measure its overall impact on behavior change. After watching the documentary in our study, gains pre to
posttest scores indicate that overall students in our study felt more at risk for HPV, were confident in their ability to seek out and
receive the vaccine and they had a greater intention to start the HPV vaccination series.
Conclusion: With more young adults streaming television on services like Netflix and watching documentary series, public health
should explore using messaging in media as a tailoring strategy to improve health outcomes.
Keywords: Health communication, public health, narratives, persuasion, young adult, Human papillomavirus (HPV), cancer
prevention
INTRODUCTION
HPV Vaccination
Human Papillomavirus (HPV), a sexually transmitted
infection, is a highly prevalent disease (Centers for Disease
Control and Prevention, 2017a; Nan, 2012). Approximately
79 million Americans are infected with HPV, with 14
million becoming newly infected annually (Centers for
Disease Control and Prevention, 2017a). HPV is the primary
cause of cervical cancer in the United States (Nan, 2012)
and the most common HPV-associated cancer among
women (Centers for Disease Control and Prevention,
2018a). In the United States, approximately 4,000 women
die from this type of cancer each year (2.3 deaths per
100,000 persons) (National Cancer Institute, 2018;
USCSWG, 2014). Oropharynx cancers are the most

common HPV-related cancers among men (Centers for
Disease Control and Prevention, 2018a). Each year, there
are 3.9 deaths per 100,000 persons attributed to oral cavity
and pharynx cancer (National Cancer Institute, 2018).
Cancer of the anus is also associated with HPV among men
(Centers for Disease Control and Prevention, 2018a). The
number of deaths among men per year associated with this
cancer is 0.3 per 100,000 persons and (National Cancer
Institute, 2018). The HPV vaccine protects against persistent
infection of HPV subtypes associated with most HPV
cancers (Centers for Disease Control and Prevention, 2017b;
Rothman, 2009). The vaccine is recommended for males
and females aged 9-26 (Meites, et al. 2016). The vaccine is
highly effective. It has been shown to prevent 90-100% of
new high-risk HPV infections among women not infected

with HPV at time of vaccination (Herrero, et al. 2015).
Since the vaccine was introduced, 4- and 9-valent type HPV
infections have decreased among vaccinated women
(Spinner, et al. 2018). The vaccine is also effective at
preventing HPV related anogenital disease in vaccinated
men (Goldstone et al., 2018) and reduces the prevalence of
oral HPV among young adults in the US (Chaturvedi et al.,
2018). In 2017, HPV vaccination coverage increased 5%
among teenagers, compared to 2016, with 65.5% of teens
having one or more doses of the vaccine (Walker et al.,
2017). However, vaccination coverage is lower among rural
teens compared to urban residents, likely related to a lack of
knowledge about HPV and awareness of the vaccine
(Walker et al., 2017). Overall, adolescent HPV vaccine rates
remain suboptimal in the US (Reagan-Stiner et al., 2016,
Ragan et al., 2018, Rahman et al., 2015) and those rates are
even lower among older-aged college students, with 18 to
21-year-old female and male college students more likely to
be vaccinated than 22 to 26-year-old female and male
college students (Thompson et al., 2016). While vaccination
rates have increased among college students since 2009,
there was a lower increase among single women,
Non-Hispanic Black men and women, and men that were
married or living with their partner (Thompson et al., 2016).
HBM Theoretical Model
According to the Health Belief model (HBM), disease
prevention techniques are used by individuals who are well
informed, perceive themselves to be at risk, are motivated to
change their behavior, and feel capable of using prevention
strategies (St. Lawrence and Fortenberry, 2007; Glanz,
Rimer, & Viswanath, 2008; Bahrami and Zarani, 2015). In
order to reduce the risk of contracting a sexually transmitted
infection, individuals must be knowledgeable about
transmission and prevention methods (Fisher and Fisher,
1992; St. Lawrence and Fortenberry, 2007). Many
Americans are unaware of HPV’s prevalence and mode of
transmission (Blake et al., 2015; Sandfort and Pleasant,
2009). This knowledge varies based on level of health
literacy, education, age, and race (Blake et al., 2015). While
many college students are knowledgeable about HPV’s link
to cervical cancer, they tend to be unaware of the link to
genital warts and skin-to-skin transmission (Gerend and
Magloire, 2008; Sandfort and Pleasant, 2009).
Additionally, many people do not perceive themselves at
risk for HPV (Sandfort and Pleasant, 2009; Blake et al.,
2015). This is likely related to the lack of understanding that
HPV is highly prevalent (Blake et al., 2015; Gerend and
Magloire, 2008; Sandfort and Pleasant, 2009). In fact, low
perceived risk in a commonly cited barrier to vaccine intent
(Patel et al., 2012; Ragan et al., 2018). In order for a
knowledgeable, motivated individual to actually change
their risky behavior, they must have the skills to perform the
recommended preventive behaviors (St. Lawrence and
Fortenberry, 2007). Individuals must feel they are skilled

enough to act on their knowledge and motivations in order
to initiate and maintain preventive behavior (Fisher and
Fisher, 1992). This skillfulness occurs when self-efficacy or
confidence to change a behavior or engage in a new
behavior is high. This leads them to a greater intention to
access and obtain the vaccine and complete all HPV vaccine
doses; thus adopting a new behavior (Darville et al., 2018).
Transportation-Imagery Model
Communication and social psychological theories of
narrative are now being applied to health-behavior research
to better understand how narratives, as opposed to statistical
evidence and appeals to logic and reason, have the power to
impact behavior change (Hinyard and Kreuter, 2007,
Krakow et al., 2017). Research now highlights how
narratives enable viewers to remember scientific facts and
tie them to prior experiences (Glaser et al., 2012).
Narratives
are
also more likely to promote
health-information seeking among viewers, compared to
non-narrative messages (Lemal and Van den Bulck, 2010).
Application of the transportation-imagery model is
particularly useful for understanding the influence of
narrative documentaries on belief change and behavior
change. Green and Brock (2000, p. 703), posit that viewers
are transported into the narrative world and their beliefs may
be changed through “emotional reactions, mental imagery,
and a loss of access to real-world information.” Persuasion
takes place because viewers develop strong emotional
connections to the story characters, believe the story to be
actual experience, and are less likely to argue against the
beliefs of the characters (Green and Brock, 2000).
According to docutainment research, transportation is often
associated with knowledge acquisition (Glaser et al., 2012).
Furthermore, among the less educated and those not
personally impacted by disease, viewing narratives on
cancer is associated with greater likelihood of undergoing
cancer screening (Kreuter et al., 2010). Narratives have the
ability to empower the viewer and increase self-efficacy by
showcasing an individual who was able to overcome
barriers and perform an action such as cancer screening or
vaccination (Krueter et al., 2007). They can also increase
viewers’ perceived efficacy of the prevention method
(Krueter et al., 2007). Individuals who view a narrative
about cancer screening may be more convinced that
preventive screening will save their life than someone who
is presented with statistical information about cancer
screening (Kreuter et al., 2007). HPV researchers found
that, when compared to statistical messages on HPV, hybrid
messages containing statistics and a narrative message
elicited greater perceived risk of getting HPV, especially
when the narrative was first-person rather than third-person
(Nan et al., 2015). This increased risk perception can
indirectly impact participants’ intention to obtain the HPV
vaccine (Nan et al., 2015). Researchers have found that
cervical cancer narratives are more likely to transport
viewers and potentially increase their intent to get the HPV

vaccine if they feature cancer survivors who face a social
barrier to vaccination (perceived promiscuity, etc.)
compared to those with characters that face structural
barriers (access to vaccination, etc.) or die from their
condition (Krakow et al., 2017). Others found that viewers
who were more fully immersed in a narrative film about
HPV and felt the plot was relevant to their own life were
more likely to view the HPV vaccine as effective (Frank et
al., 2015).
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While there have been several studies that have explored the
effectiveness of HPV narratives on HPV vaccination, the
majority of these studies tested the effectiveness of
narratives via stories published on cancer advocacy
organization or informative websites (Krakow, et al., 2017;
Kim & Nan, 2019), public service announcement (Nan &
Futerfas & Ma, 2017) family / peer communication and
healthcare provider recommendation (Hopfer & Clippard,
2011). And of the few media (film) studies that have been
conducted, the narrative integrated has been based on a
fictional story to communicate about the importance of HPV
detection and prevention (Walter et al., 2017; Frank et al,
2015) or have focused specifically on key demographic
groups such as Latinos or African Americans (Frank et al.,
2015). The main objectives of previous studies also explore
the processing, persuasion and first person vs. second
person impacts of the message and are often done using
experimental design, whereas our study highlights real
stories (non-fictional) from a group of diverse women who
not only differ in their diagnosis and clinical manifestation
of the effects of cancer diagnosis, but also differ in terms of
age, ethnicity, marital status, and professional
accomplishments. The documentary provides an opportunity
for viewers to follow the unique stories of each of these
women and experience the highs and lows as they transition
in their cancer journeys.
Additionally, this study aims to determine behavioral
intention (vaccine uptake) as a proxy for behavior change
using key constructs of the HBM theory. This is
increasingly important and relevant since the documentary
is currently being adopted and licenses acquired to
implement statewide screenings as a way to increase HPV
vaccination rates. Using a mixed method approach the data
collected not only gives indication of the impact of using the
narratives in “Someone you Love” documentary among the
target population but also insight on how to develop future
film-based interventions in public health. Therefore, the
objectives for the research study were to (a) determine the
effectiveness of the HPV narrative included in the
“Someone You love” documentary on HPV risk perception,
vaccine self-efficacy and behavioral intention for HPV
vaccine uptake on college students and (b) assess the
immediate impact of the documentary on HPV vaccine
initiation. Additionally, our research hypothesis for this
study are

Females will have an increased risk perception for
the HPV virus, increased self –efficacy, and
increased behavioral intention to receive the HPV
vaccine.
Caucasian students (all genders) will have an
increased risk perception for the HPV virus,
increased self- efficacy and increased behavioral
intention to receive the HPV vaccine.
Sexually active students will have an increased risk
perception for the HPV virus, increased self
–efficacy and increased behavioral intention to
receive the HPV vaccine.

METHODS
Participants
The study was conducted at a large research-intensive
university in Georgia. To be included in the study, students
have to be currently enrolled, between the ages of 18 – 26
years old and non-recipients of the HPV vaccine. After
Institutional Review Board (IRB) approval was received for
the study, study staff recruited eligible participants for a
3-week time period through convenience sampling at the
beginning of the Fall semester. A variety of marketing
strategies were used to enlist participants. These tactics
included tabling events, flyers in residence halls and
buildings throughout campus (see Figures 1 & 2),
announcements in university classes, email distributions
over departmental and college listservs and provided
freshmen seminar credits to recruit participants for the
documentary screening (see Figure 3 & 4).

Figure 1
Marketing Flyer used to recruit students for the documentary screening (Option 1)

Figure 2
Marketing Flyer used to recruit students for the documentary screening (Option 2)

Figure 3
Online Recruitment via Freshman Seminar Course

Figure 4
Example of Recruitment via Departmental and College Listservs

On all marketing materials, a link was provided to the Super
SaaS (2018) scheduling software to allow eligible
participants to reserve a spot for the documentary screening
event that best fit their schedule. Each screening event was a
total of 2 hours and the day varied. Four screenings were
conducted over a one-month period allowing for a total of
50 participants to sign up per screening. After signing up
for a screening date and time, study participants were
emailed by research staff and provided their Participant ID
number and a link to an electronic informed consent and the
pre-assessment survey.

Walmart gift card as incentive after completing the post
assessment survey. Before leaving the event, all participants
were notified that representatives from the Northeast Health
District were present to provide confidential health
education/ counseling and the 1st dose of the HPV vaccine to
anyone who were interested in auxiliary private rooms. One
month after the completion of the documentary screenings,
students who previously agreed to participate in the
follow-up survey were contacted via email. After
completing the follow up survey, participants were provided
with a $5 Walmart gift card as an incentive.

Stimulus

Measures

The “Someone You Love: The HPV Epidemic”
documentary was for this particular research project. The
film was developed by Frederic Lumiere in 2014 as an
advocacy film and tool to educate medical professionals and
the general public about the human papillomavirus (HPV)
and the cancers associated with infection. Narrated by
Vanessa Williams provides an in depth look into the lives of
five women (Christine, Kelly, Tamika, Kristen and Susie)
who have been diagnosed with the HPV. The film in a
storytelling narrative follows the medical journey of the
women, its effects on the family and the outcomes that
result. Ultimately, this feature length film highlights the
stories of “struggle tragedy and triumph surrounding this
complicated and often misunderstood infection” (Lumiere,
Hefti & Staurulakis, 2018) The Department of Public Health
acquired the licensure of this documentary in June 2018
permitting free screenings of the documentary in the state of
Georgia.

The questionnaire used in this study for the pre and post
assessment survey collected data on age, race, ethnicity,
student classification, health insurance, spirituality and
current sexual health beliefs and practices (Division of STD
Prevention, 2015; Ward, Dahlhamer, Galinsky, & Joestl,
2014). Because many public health scales and survey tools
do not accurately measure sexuality and sexual orientation,
the Kinsey Scale was adapted and integrated as a measure
(Gillis & Jacobs, 2017).

Procedure
Once participants completed the electronic informed
consent and pre-assessment survey administered through
Qualtrics their spot for the screening was re-confirmed by
study staff. Students who did not meet eligibility
requirements reservations were removed from the Super
SaaS software and notified of their ineligibility. On the day
of each screening and outside of the screening events,
participants had to check in with study staff to confirm that
their pre-assessment survey was completed. Upon
successful check – in, participants were informed of
available refreshments and provided a 15-20-minute
window to get settled. Following this, participants were
thanked for participating and watched the documentary for a
total of 1 hour and 20 minutes in an intimate enclosed
screening room located in the University’s student union.
During this time, research staff emailed each post
assessment survey. After the documentary ended, students
were asked to complete the post assessment survey using
their own personal mobile devices and in silence to reduce
the risk of lack of independence of their individual
responses. Each participant was provided with a $20

Scale items included on the survey were adapted from a
scale used in previous HPV studies (Katz, Kam, Krieger, &
Roberto, 2012). Three items measured risk perception, three
items measured self-efficacy, and four items measured
behavioral intention and were measured using a 7-point
Likert scale (1 = strongly disagree to 7 = strongly agree).
The scales were within the acceptable range with respect to
internal consistency for self-efficacy (α = 0.812) and
intention (α= 0.836). Although risk perception was a
variable of interest for the previous study the scale was used
in, Cronbach’s alpha was not reported. In our study
however, Cronbach’s alpha of 0.910 was reported for risk
perception which indicated an excellent level of internal
consistency. The questionnaire was also used to capture
qualitative data using open ended questions. Participants
were asked (a) What are some things you liked about the
documentary and (b) In what ways can the documentary
improve? What changes do you suggest? These qualitative
questions were only included in the post test and not the
pretest to reduce the risk of unintentionally priming the
participants.
The follow up survey used in this study, consisted of 5
questions. The questions asked if and where the first dose of
the HPV vaccine initiated, how many doses were completed
after watching the documentary, if the participant intended
to complete all 3 doses and if the documentary directly
influenced their decision.
Data Analysis

All analyses were performed using Statistical Package for
the Social Sciences (SPSS) version 25.0 software.
Descriptive statistics were calculated for each dependent
variable. A dependent samples t-test was conducted to
determine if differences in the scale scores for each variable
existed between pre and post viewing of the HPV narrative
in the documentary “Someone You Love”. Analysis of
Covariance (ANCOVA) was conducted to determine if a
difference existed in the post-test scores when controlling
for the pre-test scores for several conditions related to
gender, race and ethnicity, religious affiliation, sexual
orientation, type of insurance and student major. Scale items
were measured on a 7-point Likert scale (1 = Strongly
Disagree to 7 = Strongly Agree) for the scales of Risk
Perception, Self-Efficacy and Behavioral Intention.
Summed scores were created for each of the three scales.
The three summed scores served as the dependent variables
for all analyses.
RESULTS
Demographics
A sample of 151 students at the University of Georgia
completed the pre-test survey and 126 students from the
same sample of students completed the post-test survey.
After removal of incomplete records, a sample of 120
students that completed both the pre- and post-test scores
were collected and analyzed. Only 54 of the 120 students
completed the Follow-Up survey. Participants were mostly
female (91, 76.5% female), freshman (48, 40.0%) freshmen
and Liberal Arts majors (48, 40.0%) Liberal Arts. The
distribution of race and ethnicity was (58, 48.3%)
Caucasian, (38, 31.7%) Asian, (18, 15.0%) Black or
African-American, (4, 3.3%) Hispanic and (2, 1.7%) Bi-or
Multi-Racial.
Current Health Practices
Study participants were generally heterosexual (97, 81.5%
heterosexual), and indicated a relationship status of single
(78, 65.5% single). When asked about their sexual activity,
(51, 42.9%) indicated they had been sexually active within
the last six months and (52, 74.3%) indicated they had 1- 4
sexual partners. Condoms were the birth control method
used the most (45, 36.8%). Most of the study participants
have never had a sexually transmitted disease (115, 97.5%).
In order to have participated in the study, none of the
participants had to be recipients of the HPV vaccine or
initiated even the 1st dose of the HPV vaccine.
Risk Perception
Three items were used to measure Risk Perception. Thus,
summed scores ranged from a minimum of 3 to a maximum

of 21. A dependent sample t-test was conducted to
determine if the HPV narrative in the documentary
“Someone You Love” resulted in significant and positive
increase in post-test scores from students’ pre-test scores on
Risk Perception. The results showed a positive and
significant effect. The mean difference between pre- and
post-test scores on Risk Perception was 7.150, t (119) =
14.502, p<.001, d=1.324. (see Table 1). Results for gender
assignment at birth showed a significant difference in
post-test scores when holding pre-test scores constant
between males and females, F(1, 116) - 17.171, p<.001, ᶯ2 =
.129 The post-test scores for the females, adjusted for the
pre-test score average of 20.81, was 28.89 compared to an
adjusted average of 24.79 for males. Mean differences
between the pre- and post-tests for Risk Perception were not
significant for race and ethnicity, religious or spiritual
affiliation, student major, and type of insurance. There were
no significant mean differences in Risk Perception for those
that were sexually active and those that were not sexually
active. The type of sexual behaviors the student engaged in
also did not influence their response to the documentary.
Also, there was also no mean difference due to sexual
orientation.
Table 1
Means for Risk by Gender

Male
Female

Pre-test
20.71(4.46)
20.81(4.88)

Post-Test
24.79(5.96)
28.89(4.74)

Self-Efficacy
The Self-Efficacy scale contained three items. Therefore,
summed scores ranged from a minimum of 3 to a maximum
of 21. Dependent t-test results showed a positive and
significant effect of the narrative on vaccine Self-Efficacy.
The mean difference between pre-and post-test scores on
Self-Efficacy was 1.050, t (119) = 1.761, p = .04, d=.161
(see Table 2).
Table 2
Means for Self-Efficacy by Gender

Male
Female

Pre-test
21.96(7.13)
22.98(7.22)

Post-Test
23.79(3.79)
23.54(4.29)

There was not a significant difference in post-test scores
when holding pre-test scores for gender. The results for race
and ethnicity showed a significant difference in post-test
scores when holding pre-test scores constant for
Self-Efficacy, F (4, 114) = 3.186, p = .016, ᶯ2 = .101.
Bi-racial or Multi-racial students had the highest adjusted
mean followed by Asians. Black or African-American

students had the lowest adjusted mean. A post-hoc analysis
using a Bonferroni adjusted alpha of .0125 showed a
significant mean difference between Asians and Black or
African-American individuals, p = .001. Mean differences
between the pre- and post-tests for Self-Efficacy were not
significant for religious or spiritual affiliation, student
major, and type of insurance. As with Risk Perception there
were no significant mean differences in Self-Efficacy for
those that were sexually active and those that were not
sexually active and the type of sexual behaviors the student
engaged in also did not influence their response to the
documentary. There was also no mean difference due to
sexual orientation.

that HPV can bring to your health. I think that it
was quite informative and I learned many things
that I did not know before about the virus. I also
think that it was very important to show the
perspectives of different people and how different
people can be affected.”

●

“I really liked how the documentary displayed
different stories from different women. They all
had the same struggle, but different lifestyles and
outcomes. I liked how in-depth each story got as
well. I was particularly impacted by how we got to
see all of Kelly's story. I also liked the mix of
testimonials from the women and scientific facts
from the doctors. You got to see both sides. It was
definitely emotional and got the message across.”

●

“I liked how it followed the journey of each person
who experienced HPV. I especially liked how it
followed Kelly's journey and even though it had a
bittersweet ending her spirit continues to live on. I
thought it was important how they explained that
having HPV is normal and does not make you any
less of a person.”

Behavioral Intention for HPV Vaccine Uptake
Four items were used to measure HPV vaccine uptake. The
summed scores on the scale ranged from 4 to 28. Dependent
samples t-test results indicated a positive and significant
mean difference between the pre- and post-test scores for
behavioral intention for HPV Vaccine uptake on college
students. The results for all three dependent variables
showed a positive and significant effect. The mean
difference between pre- and post-test scores was 4.775, t
(119) = 10.300, p<.001, d=.941 (see Table 3).
Table 3
Means for Behavioral Intention by Gender

Male
Female

Pre-test
15.96(5.56)
18.21(5.82)

Post-Test
21.86(6.35)
22.88(5.03)

Results for individual major yielded significant results for
HPV Vaccine Uptake only, F (11, 107) = 1.916, p = .045 ᶯ2
= .165. Mean differences between the pre- and post-tests
for HPV Vaccine Uptake were not significant for gender
race or ethnicity, religious or spiritual affiliation, and type of
insurance. As with Risk Perception and Self-Efficacy there
were no significant mean differences in HPV Vaccine
Uptake for those that were sexually active and those that
were not sexually active, and the type of sexual behaviors
the student engaged in also did not influence their response
to the documentary. There was also no mean difference due
to sexual orientation.

Students were also asked “In what ways can the
documentary improve? What changes do you suggest?”
Some of the answers are included below:
●

“I thoroughly enjoyed learning about each story
although I would have liked a more scientific
aspect to what it is and how it is able to be stopped.
Also each story was about females and at this point
I don’t know how it affects males. I don't know
how this is preventable besides the vaccine and
condoms. I would like to be more aware of the
science behind why they made such a common
virus.”

●

“At first I thought it was a little long but honestly
every moment was relevant and I don't think
anything should be cut. There is some confusion
still on how this virus originated, how someone
with one partner can still get the virus, especially if
your partner has only been with you.”

●

“I kind of wish that it showed more scientific
evidence and statistics in tables and graphs but
otherwise it was good. But also I wish it showed
men victims as well who have the virus and have
suffered from it. It doesn't make sense to tell men
they can get it too but not interview any of them. It
seems like a biased narrative.”

Qualitative Findings
Apart from the quantitative data, qualitative data was also
collected. Students were asked “What are some things that
you liked about the documentary?” Some of their answers
are included below:
●

“I loved the rawness of the documentary; it didn't
dance over the topic or shy away from the severity

HPV Vaccination Uptake on Day of Screenings
Although the vaccine was offered immediately after each
screening of the documentary. Only twenty students (16%)
of students received the first dose of the HPV vaccine series
at the screening events. The breakdown for each screening
were as follows: Wednesday night (n=4), Monday night
(n=6), Monday night (n=5), Tuesday night (n=5).
Follow-Up Survey
The follow-up survey was completed by 54 individuals. Of
those students that responded to the follow-up survey,
(43,79.5%) were female, (45, 83.3%) were heterosexual,
(28, 51.9%) were sexually active and (33, 61.1%) were
single, not in a committed relationship. For the question
“Have you initiated the HPV vaccine”, (28, 51.9%)
answered “Yes” and (26, 48.1%) answered “No”. Of those
that answered “Yes”, (24, 85.7%) were female. The
majority of the students (36, 66.7%) indicated they planned
to complete all three doses of the vaccine.
Most indicated they began the vaccine series at the Health
Department the day of the documentary streaming (44.2%)
or at their family physician office (32%) or the UGA
Student Health Center (12%). Over half (28, 51%) of those
that responded to the Follow-up Survey indicated that the
documentary “Someone You Love” directly influenced their
decision to start the vaccine series. Of those that answered
“Yes”, (24, 85.7%) were female. Only (7, 13.0%) indicated
the documentary did not influence their decision.

because young adults and collegiate age populations engage
in the riskiest of sexual health behaviors and oftentimes
have the greatest misconceptions of the disease and need to
be vaccinated (Albright & Allen, 2018).
Despite college students falling outside of the recommended
age range for best immune response to the HPV vaccine (9 –
12 years old), they do fall within the “catch up” vaccination
group (Mehu-Parant et al., 2010). A young adult is
categorized within this “catch up” vaccination group if they
did not receive the vaccine during the recommended age
groups (Silverberg et al., 2018). Data indicates that although
the FDA licensed the quadrivalent human papillomavirus
vaccine (HPV4) Gardasil in 2006 and bivalent human
papillomavirus vaccine (HPV2) Ceravix in 2009 for use in
females aged 9 – 26 years, the Advisory Committee on
Immunization Practices (ACIP) only recommended routine
vaccination for females aged 11 or 12 starting as early as 9;
with catchup between 13 through 26 years old (Center for
Disease Control and Prevention, 2010; Markowitz et al,
2014). Recommendation for boys aged 13 – 21 were not
introduced by the Centers for Disease Control and
Prevention
(CDC)
until
2011,
with
inclusive
recommendations for men aged 22 – 26 if they identified as
men who have sex with men (MSM) or had an
immunocompromised
condition
such
as
human
immunodeficiency virus (HIV) (Center for Disease Control
and Prevention, 2011; Whitman & Cajigal, 2016).
Expanded male recommendations for older males were not
established by the FDA until 2015 and adopted by the ACIP
until 2019. (Howard, 2019; Immunization Action Coalition,
n.d).

DISCUSSION
Current state of HPV vaccination in Georgia
Although Georgia vaccination coverage rates have been
improving in the last decade, there is still opportunity for
improvement. According to 2016 statistics it is estimated
that 67.3% of adolescents in Georgia (aged 13–17) initiated
the vaccine series (77.0% female and 58.0% male
adolescents) while only 45.6% completed the full series
(55.4% female and 36.2% male) (Walker et al., 2017). By
2017 these data points increased indicating incremental
improvements. Within Region IV (Alabama, Florida,
Georgia, Kentucky, Mississippi, North Carolina, South
Carolina and Tennessee), Georgia currently stands 2nd
trailing behind North Carolina for 1 dose initiation and
vaccine completion among adolescents aged 13 – 17 years
old (Walker et al., 2018). While the Center for Disease
Control and Prevention (CDC) reporting databases mostly
track adolescent vaccination initiation and completion rates
to correspond with the newer ACIP recommendations (2
dose if initiated before 15th b-day, 3 doses after), young
adults are oftentimes not discussed (Meites, Kempe &
Markowitz, 2016). This is increasingly cause of concern

Because a large proportion of college age students did not
get vaccinated when initial recommendations were
published for both males and females, there are benefits
such as protection and cancer prevention if vaccinated up to
age 26 (Centers for Disease Control and Prevention, 2018).
Although there have been several interventions completed to
date targeting college age populations, many of these studies
used traditional programmatic approaches to changing
behavior without tailoring their messages to their complex
communication needs (Friedman & Shepeard, 2007; Priest
& Knowlden, 2015). According to Hopfer, “communication
source may play an even more important role when
uncertainty surrounds an advocated health behavior such as
a new vaccine” (2012, p.174). When we look at where
young adults consume information (novels, magazines,
radio, music lyrics, online news content and television) we
know that those narrative channels command more
attention, change beliefs and are more predictive of
changing behavior when compared to traditional platforms
such as advertisements, sermons, editorials or billboards
(Green & Brock, 2000).
Entertainment Communication Impact on Health

Entertainment -Education or entertainment narrative has
emerged as a growing field in communication with greater
implications in public health. It is a strategy that embeds
persuasive messages within popular media content to
improve attitudes, influence awareness, increase knowledge
and change behavior (Moyer- Guse, 2008). The literature
has cited several benefits to using narratives in media
compared to traditional communication channels or
approaches. According to Hopper (2012), “the advantages
of a narrative over an informational approach include more
effectively reaching audiences who are less involved,
resistant, have low knowledge about the health issue at
hand, or who are in early stages of behavior adoption.”
Despite its’ promise, it has more prominently been applied
in areas such as HIV prevention, domestic violence, sexual
assault/rape and safe sex practices (particularly condom use)
(Moyer-Guse,2008; Moyer- Guse & Nabi, 2010)
Since 2014, the "Someone you Love" documentary has been
adopted for public screenings in nearly 18 states throughout
the United States (Lumiere, Hefti & Staurulakis, 2018).
While the documentary shares light on the impact of HPV
transmission and its deadly impact, no formal research study
has been done to measure its overall impact on behavior
change. After watching the documentary in our study, gains
pre to posttest scores indicate that overall students in our
study felt more at risk for HPV, were confident in their
ability to seek out and receive the vaccine and they had a
greater intention to start the HPV vaccination series. Despite
this however, we did not achieve all of the aims sought out.
We hypothesized that females, Caucasians and students who
were sexually active would have an increased risk
perception, self-efficacy and thus behavioral intention.
While there were no statistically significant differences
when exploring different variables related to behavioral
intention among females, Caucasians and sexually active
students, we did see statistically significant differences
related to gender (female) for risk perception and race
(bi-racial or /multiracial and among Asians) for
self-efficacy. The results obtained for risk perception among
females in our study is not surprising being that the focus of
the documentary stories were 5 women. Seeing themselves
as the women, and connecting to the parallels of these
women through their journeys allowed for female students
to identify with them and thus led to increased risk
perceptions. However, because the documentary did not
show any of the women being vaccinated (although it did
integrate vaccination messages as a prevention strategy) it
could have affected female viewers’ confidence in their
ability to be vaccinated and thus thwarted their overall
behavioral intention. Knowledge of the vaccine is optimal,
however viewing someone’s success with initiating and
completing the vaccination series could have had an
increased impact on vaccination initiation following the
viewing session.

Additionally, because the documentary highlighted the lives
of 5 women diagnosed with HPV, all racially diverse
(White, African American and Asian); the results seen
among bi/ multi-racial and Asian participants are not
surprising. While Caucasian (white) women have been one
of the key priority population groups in the United States for
HPV vaccination, we see that there are still key differences
among minority women when compared with non -Hispanic
white women for prevention strategies such as pap smear
screening affecting cervical cancer incidence and mortality
rates (Carrasquillo et al, 2018). In the “Someone You Love”
documentary the narrative for the minority women
compared to non – Hispanic women however differed from
what generally occurs in everyday society. Two of the white
women died from their cervical cancer diagnosis, while the
remaining three women (n=3) were able to beat their
diagnosis and thrive as cancer survivors. The use of these
testimonials could have in fact empowered women in our
study, thus contributing to the results seen.
Limitations and Future Recommendations
Despite its successes, there were some limitations to the
study. The first is that although the effect of education
entertainment on HPV outcomes was measured, the
theoretical framework used was more aligned with public
health or behavior change. Additionally, because two of the
constructs measured in this study came from the Health
Belief Model and behavioral intention was used as a proxy
for behavior change, future studies should test all constructs
of the Health Belief Model (i.e. perceived benefits and
perceived barriers). Currently, studies exploring the effect
on persuasion and narratives typically apply the extended
elaboration likelihood model (E-ELM) or the entertainment
overcoming resistance model (EORM) or heuristics
-systematic model (HSM) as their theoretical foundation
(Moyer- Guse & Nabi, 2010; Green & Brock, 2000).
Furthermore, transportation (also referred to as immersion),
is also measured in entertainment education. This is because
when someone is transported, they are less likely to respond
negatively to the narrative, they are less likely to counter
argue a claim or storyline, they are more likely to redefine
their attitudes and beliefs, warranting a convergent process
towards behavior change (Green & Brock, 2000). Based
upon transportation theory and research on HPV narratives,
the film may have been more impactful if it (1) focused on a
more diverse group or women that were closer to the
viewers’ ages (identification); (2) had less third-person
narrative by Vanessa Williams and focused more on the first
– person narratives of the women; and (3) included only
stories of survivors rather than 2 stories about death from
HPV/ cervical cancer. Based on Krueter et al., watching this
film where one woman did “everything right” (got regular
Paps, knew about HPV, went through all of the treatments)

and still died in the end, may lead viewers to believe less in
the screening/treatment process and thus have less
self-efficacy around HPV prevention (2007). Future studies
should explore the addition of a persuasive model on
communication effects as well as measure transportation
and immersion.
The study used a pretest/posttest design with all participants
exposed to the stimulus and no random assignment. The
study also used a convenience sample, which means that the
results cannot be generalizable to population groups outside
of our sampling parameters. Future studies should explore
testing the documentary using an experimental design with a
true control or comparison group. This provides more
validity concerning the documentary’s effectiveness when
compared to current educational strategies to inform
collegiate students on the need to initiate and complete the
HPV vaccine.
There was very high attrition from pretest to post-test (17%)
and post-test to the follow-up survey. Upon enrolling in the
study, the researchers limited the numbers of seating based
upon the capacity of the screening rooms to avoid being at
over capacity. However since the screening events were
scheduled during the same times at many afternoon course
labs, extracurricular events and club meetings, many
students did not show up accounting for the high attrition
rates seen after completing the pre assessment survey.
Despite this however, because each participant had a
specific Participant ID number, any pre-test that did not
have an accompanying posttest was not included in the data
analysis. Future studies should explore varying times in the
semester to offer screening events to reduce any potential
conflicts. Additionally, not all participants did not complete
the follow up survey despite being incentivized with a $5
gift card. This may have been due to a few reasons (1) the
timing of the email to complete the follow up study
coinciding with the end of the semester and increased
workloads on students (2) the students not seeing the $5 as
enough of an incentive to warrant completing the survey.
Therefore, future studies should consider having additional
funds to collect that information, or alternate strategies to
get a more accurate account of the number of students who
have initiated the HPV vaccine following the documentary
screening.
While qualitative data was collected from research study
participants, the depth of information that could have been
captured was limited to an open-ended response area on a
survey.
To truly measure immediate reactions, the
effectiveness of the narrative and storyline focus groups
should be facilitated with the target population with
segmentation based upon race and gender. To explore what
future education – entertainment mediums should consider
when tailoring or targeting their communication messages,
qualitative studies should also be conducted with priority

subgroups or disparity groups such as sexual minorities
(LGBTQ+) and males.
Lastly, while this study measured immediate uptake of the
HPV vaccine following the documentary screening and used
the behavioral intention measure from the Theory of
Planned Behavior (TPB) as a proxy to behavior change, it
did not predict long term vaccination completion rates
among the college age population. Future studies should
track college students from initiation to vaccine series
completion to adequately measure intervention success.
CONCLUSIONS
With more young adults streaming television on services
like Netflix and watching documentary series, public health
should explore using persuasive messaging in media as a
tailoring strategy to improve health outcomes and motivate
behavior change. Apart from providing information,
educational entertainment can also reduce stigma, and
promote healthy behaviors. As mentioned in our discussion,
we did not achieve the research aims associated with this
study. While we hypothesized that females, Caucasian
students (all genders) and those who were sexually active
will have an increased risk perception for the HPV virus,
increased self –efficacy, and increased behavioral intention
to receive the HPV vaccine; our results indicated otherwise.
In fact, we only obtained statistically significant results for
females as it related to risk perception for contracting the
HPV virus. Therefore, future research is needed to (a)
develop a documentary that highlights the HPV narratives
of all persons (diverse population groups) and (c) integrate
messages that not only show the health impacts of
contracting the HPV virus, but how to enact the necessary
steps to prevent and treat (if caught early enough) for that
diverse population group. We believe that because the
documentary did not include this information on how to go
about preventing being diagnosed with HPV related health
outcomes (such as genital warts or cancer), it directly
impacted viewer’s confidence and thus intention to change
their behavior. Therefore, apart from the storyline or
narration, future education entertainment strategies focused
on improving HPV vaccination outcomes, should also
consider the quality of the production, the characters used,
the extent to which the participant identifies or finds
similarity between self and the character, and the level of
persuasive messaging included throughout. Additionally,
future research should also explore innovative ways (cues to
action) to increase post viewing vaccination among the
target population, as less than 50% of our sample actually
initiated vaccination one month after watching the
documentary. By making these changes, future approaches
could be successful in achieving positive HPV vaccination
and prevention outcomes in a tailored manner for young
adults.
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